167 related articles for article (PubMed ID: 26748705)
1. Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis.
Elhanati S; Ben-Hamo R; Kanfi Y; Varvak A; Glazz R; Lerrer B; Efroni S; Cohen HY
Cell Rep; 2016 Jan; 14(2):234-42. PubMed ID: 26748705
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice.
Cheng L; Zhu Y; Han H; Zhang Q; Cui K; Shen H; Zhang J; Yan J; Prochownik E; Li Y
Cell Death Dis; 2017 Jul; 8(7):e2916. PubMed ID: 28703810
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
4. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
5. Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver.
Xiang X; Ohshiro K; Zaidi S; Yang X; Bhowmick K; Vegesna AK; Bernstein D; Crawford JM; Mishra B; Latham PS; Gough NR; Rao S; Mishra L
FASEB J; 2022 Jun; 36(6):e22335. PubMed ID: 35506565
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.
Marquardt JU; Fischer K; Baus K; Kashyap A; Ma S; Krupp M; Linke M; Teufel A; Zechner U; Strand D; Thorgeirsson SS; Galle PR; Strand S
Hepatology; 2013 Sep; 58(3):1054-64. PubMed ID: 23526469
[TBL] [Abstract][Full Text] [Related]
7. Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma.
Tao NN; Ren JH; Tang H; Ran LK; Zhou HZ; Liu B; Huang AL; Chen J
Biochem Biophys Res Commun; 2017 Apr; 485(4):713-719. PubMed ID: 28238784
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
[TBL] [Abstract][Full Text] [Related]
9. The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth.
Zhang J; Liu H; Pan H; Yang Y; Huang G; Yang Y; Zhou WP; Pan ZY
Biochem Biophys Res Commun; 2014 Sep; 452(3):575-80. PubMed ID: 25181338
[TBL] [Abstract][Full Text] [Related]
10. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
11. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
12. miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.
Feng J; Wang J; Chen M; Chen G; Wu Z; Ying L; Zhuo Q; Zhang J; Wang W
Oncol Rep; 2015 Feb; 33(2):713-20. PubMed ID: 25482402
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
14. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.
Kim HS; Xiao C; Wang RH; Lahusen T; Xu X; Vassilopoulos A; Vazquez-Ortiz G; Jeong WI; Park O; Ki SH; Gao B; Deng CX
Cell Metab; 2010 Sep; 12(3):224-36. PubMed ID: 20816089
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
[TBL] [Abstract][Full Text] [Related]
16. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ inhibits sirtuin 6 gene expression in intestinal epithelial cells through a
Liu F; Wang X; Geng H; Bu HF; Wang P; De Plaen IG; Yang H; Qian J; Tan XD
Am J Physiol Cell Physiol; 2020 Apr; 318(4):C732-C739. PubMed ID: 32049548
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
[TBL] [Abstract][Full Text] [Related]
19. SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα.
Naiman S; Huynh FK; Gil R; Glick Y; Shahar Y; Touitou N; Nahum L; Avivi MY; Roichman A; Kanfi Y; Gertler AA; Doniger T; Ilkayeva OR; Abramovich I; Yaron O; Lerrer B; Gottlieb E; Harris RA; Gerber D; Hirschey MD; Cohen HY
Cell Rep; 2019 Dec; 29(12):4127-4143.e8. PubMed ID: 31851938
[TBL] [Abstract][Full Text] [Related]
20. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]